CAPTRUST Financial Advisors
ALBO

CAPTRUST Financial Advisors’s Albireo Pharma Inc ALBO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-115
Closed -$2K – 4498
2022
Q2 		$2K Hold
115
– – ﹤0.01% 4562
2022
Q1 		$3K Sell
115
-27
-19% -$790 ﹤0.01% 4422
2021
Q4 		$3K Sell
142
-5
-3% -$133 ﹤0.01% 4337
2021
Q3 		$5K Buy
147
+6
+4% +$186 ﹤0.01% 3978
2021
Q2 		$5K Sell
141
-6
-4% -$195 ﹤0.01% 3893
2021
Q1 		$5K Buy
+147
New +$5.43K ﹤0.01% 3762

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAPTRUST Financial Advisors's ALBO Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 115 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in ALBO in Q1 2021 and held it in 6 quarters. The position peaked at $5K in Q3 2021. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 115 Albireo Pharma Inc shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Albireo Pharma Inc in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Albireo Pharma Inc position peaked at $5K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.